Candida albicans is the most common human fungal pathogen, causing infections that
range from mucous membranes to systemic infections. The present article provides an …

Next-generation sequencing (NGS) technologies have become increasingly available for
use in the clinical microbiology diagnostic environment. There are three main applications of …

Background The emergence of antifungal resistance threatens effective treatment of
invasive fungal infection (IFI). Invasive candidiasis is the most common health care …

Candidiasis is a highly pervasive infection posing major health risks, especially for
immunocompromised populations. Pathogenic Candida species have evolved intrinsic and …

Candida albicans represents the most frequent isolated yeast from bloodstream infections.
Despite the remarkable progress in diagnostic and therapeutic approaches, these infections …

Invasive fungal diseases (IFDs) present an increasing global burden in
immunocompromised and other seriously ill populations, including those caused by …

Role of biofilm in disease development and enhance tolerance to antifungal drugs among
Candida species has necessitated search for new anti-fungal treatment strategy …

Fungal infections are a global concern and the evolution of intrinsic resistance to current
antifungals presents an alarming problem. For Cryptococcus neoformans, a human fungal …

The increasing incidence and changing epidemiology of invasive fungal infections continue
to present many challenges to their effective management. The repertoire of antifungal drugs …

Rezafungin is a long-acting, intravenously administered echinocandin for the treatment of
candidemia and invasive candidiasis (IC). Non-inferiority of rezafungin vs caspofungin for …